If you are a healthcare professional and have a question about one of Eurocept International’s products, please send us a contact request via the contact page.

Eurocept International is expanding its global outreach and is actively looking for partners to distribute its products. If you are interested to market one or more of our products in your territory, we invite you to contact businessdevelopment@euroceptpharma.com.

UCEDANE^® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).

PHEBURANE® is an alternative version of the proven niche molecule phenylbutyrate, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).

AMSACRINE® is a proven molecule used in the 2^nd line treatment of acute leukemias.

RAPYDAN® is a medicated plaster containing lidocaine and tetracaine (70mg/70mg) used to provide local anesthesia to the skin and at the same time widening of blood vessels.

SENDOLOR® morphine solution offers registered large volume (100ml) infusion bags and is available in the following concentrations 1mg/ml, 10mg/ml and 20mg/ml.

SUFENTANIL® is a proven molecule used in anesthesiology.

ESKETIV® is an alternative version of proven molecule esketamine, with notable differences to the original. This molecule is often used in anesthesiology.

GRANUPAS® is the brand name for the proven molecule para-aminosalicylic acid used as part of an appropriate combination regimen for multi-drug resistant tuberculosis which is quite rare in EU nowadays.

The molecule tobramycine is available under brand names OBRACIN® and NEBCINA®, the injectable form of tobramycine. This molecule is often used in the treatment of infections.

CEFAZOLINE®/CEFALEXINE®/CEFTAZIDIME® are proven molecules used in the treatment of infections.